| 000 | 01503 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517021910.0 | ||
| 264 | 0 | _c20160407 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a2567-689X | ||
| 024 | 7 |
_a10.1160/TH14-10-0877 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJourdi, Georges | |
| 245 | 0 | 0 |
_aAssociation rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cJul 2015 |
||
| 300 |
_a78-86 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aFactor Xa Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aProthrombin Time |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyridones _xpharmacology |
| 650 | 0 | 4 |
_aRivaroxaban _xpharmacology |
| 650 | 0 | 4 |
_aThrombin _xmetabolism |
| 700 | 1 | _aSiguret, Virginie | |
| 700 | 1 | _aMartin, Anne Céline | |
| 700 | 1 | _aGolmard, Jean-Louis | |
| 700 | 1 | _aGodier, Anne | |
| 700 | 1 | _aSamama, Charles-Marc | |
| 700 | 1 | _aGaussem, Pascale | |
| 700 | 1 | _aGouin-Thibault, Isabelle | |
| 700 | 1 | _aLe Bonniec, Bernard | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 114 _gno. 1 _gp. 78-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1160/TH14-10-0877 _zAvailable from publisher's website |
| 999 |
_c24698617 _d24698617 |
||